Clinical effect of multidisciplinary respiratory rehabilitation including nutrition support with BCAA and herbal medicine

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1090220049

Enrollment

100

Registered

2010-10-19

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory disease. lung cancer patients with poor lung function

Interventions

Intervention type:DRUG,BEHAVIOUR Name of intervention:harbel medicine (Hochuekkitou),nutrition support (Branched Chain Amino Acid) Dose form / Japanese Medical Device Nomenclature:POWDER,NOT APPLICABL

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Lung cancer patients with poor lung function meeting at least one of the following criteria: 1) VC < 80% 2) FEV1% < 70% 3) %IBW < 90%

Exclusion criteria

Exclusion criteria: 1) Severe mental disease or orthopedic disease 2) Active infection disease 3) Another active cancer 4) Pregnancy 5) Smoker 6) Severe heart disease

Design outcomes

Primary

Measure	Time frame
morbidity	—

Secondary

Measure	Time frame
respiratory function, nutrition status, ADL and QOL, adverse effect	—

Countries

Japan

Contacts

Public ContactHiroaki Harada

National Hospital Organization Kure Medical Center, Chugoku Cancer Center

haradah@kure-nh.go.jp+81-823-22-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026